Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $19.0600 (-4.41%) ($18.8700 - $19.9500) on Wed. Aug. 17, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.43% (three month average) | RSI | 4 | Latest Price | $19.0600(-4.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.4% a day on average for past five trading days. | Weekly Trend | EDIT declines -11.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(60%) IBB(59%) XBI(58%) IWO(55%) ARKK(54%) | Factors Impacting EDIT price | EDIT will decline at least -1.715% in a week (0% probabilities). VIXM(-14%) TLT(-6%) SHY(-6%) IPO(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.715% (StdDev 3.43%) | Hourly BBV | 0 () | Intraday Trend | -4.5% | | | |
|
1 - 5 Day Possible Target | $1.06(-94.44%) | Resistance Level | $23.93 | 5 Day Moving Average | $20.04(-4.89%) | 10 Day Moving Average | $21.73(-12.29%) | 20 Day Moving Average | $23.93(-20.35%) | To recent high | -48.6% | To recent low | 0% | Market Cap | $1.184b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |